NEW YORK (GenomeWeb) – Wafergen Biosystems said after the close of the market on Monday that its fourth quarter revenues grew more than threefold year over year. 

The Fremont, Calif.-based firm recorded $1.6 million in total revenues for the three months ended Dec. 31, 2014, compared to $490,465 in Q4 2013. The increase was driven by a $600,000 increase in SmartChip revenues in the recently completed quarter, compared to the year-ago quarter, as well as $500,000 in Apollo revenues in Q4 2014, compared to zero in Q4 2013, Wafergen said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.